Kotak Healthcare Fund - Regular Plan - Growth Option
₹14.9680
₹0.15 (-1.00%)
NAV as of 29 May 2026
Today's NAV — all variants
Regular · Growth
₹₹14.9680
₹0.15 (-1.00%)
29 May 2026
AMFI: 152216
Direct · Growth
₹₹15.5850
₹0.16 (-0.99%)
29 May 2026
AMFI: 152214
Regular · IDCW
₹₹14.9720
₹0.15 (-1.01%)
29 May 2026
AMFI: 152213
Direct · IDCW
₹₹15.5830
₹0.16 (-1.00%)
29 May 2026
AMFI: 152215
Returns (Lumpsum)
CAGR for periods ≥ 1 yearSIP Returns (XIRR)
₹1,000/month SIP, annualisedSIP since inception — what ₹100/month became
Real NAV backtest from day one
₹3,000
Invested
₹3,568
Value today
14.1%
XIRR (p.a.)
₹100/month SIP from fund inception · Current value as of today
Try SIP Calculator with this fund's history₹100 lumpsum at launch — value today
Invested on the fund's first NAV date
₹100
Invested
₹150
Value today
17.3%
CAGR (p.a.)
One-time investment at fund inception · Growth purely from NAV appreciation
Try Lumpsum Calculator₹6L corpus via 12-month STP from a liquid fund at inception
₹50K/month transferred from HDFC Liquid → this fund at launch
₹6,00,000
Invested
₹7,95,318
Value today
-11.4%
vs lumpsum
Direct lumpsum would have beaten STP by 11.4% — but STP reduced timing risk
Model your own STP with real NAVBeat the benchmark — ₹100/month SIP
Same SIP in this fund vs the benchmark index
This fund
₹3,568
Benchmark
₹3,121
+₹447 extra wealth vs the benchmark index
Backtest this SIP yourselfDirect vs Regular — ₹500/month over 2 years
Expense ratio drag on your actual returns
Direct plan
₹14,600
Regular plan
₹14,343
Direct earns ₹257 more on a ₹12K investment — 1.07% extra return per year
Same fund, same NAV history — only the expense ratio differs. Direct plans always outperform Regular over time.
Learn about Direct vs Regular plansFund Details
Risk Metrics
Trailing 1 year, annualised0.10
Sharpe Ratio
+0.06
Alpha
0.37
Beta
0.09
Sortino
15.72%
Std Dev
-18.27%
Max Drawdown
Portfolio Holdings
Top 50 holdings · as of Apr 2026
| Security | % NAV |
|---|---|
SUN PHARMACEUTICAL INDUSTRIES LTD. INE044A01036 | 1404.00% |
SUN PHARMACEUTICAL INDUSTRIES LTD. INE044A01036 | 1391.00% |
JB Chemicals & Pharmaceuticals Ltd. INE572A01036 | 751.00% |
Max Healthcare Institute Ltd. INE027H01010 | 696.00% |
JB Chemicals & Pharmaceuticals Ltd. INE572A01036 | 663.00% |
Max Healthcare Institute Ltd. INE027H01010 | 631.00% |
Divis Laboratories Ltd. INE361B01024 | 605.00% |
Divis Laboratories Ltd. INE361B01024 | 590.00% |
Ami Organics Ltd INE00FF01025 | 509.00% |
Fortis Healthcare India Ltd INE061F01013 | 484.00% |
Fortis Healthcare India Ltd INE061F01013 | 467.00% |
Ami Organics Ltd INE00FF01025 | 460.00% |
Cipla Ltd. INE059A01026 | 422.00% |
Lupin Ltd. INE326A01037 | 419.00% |
PARK MEDI WORLD LIMITED (PARK HOSPITAL) INE119201023 | 379.00% |
KRISHNA INSTITUTE OF MEDICAL INE967H01025 | 356.00% |
PARK MEDI WORLD LIMITED (PARK HOSPITAL) INE119201023 | 348.00% |
Apollo Hospitals Enterprise Ltd. INE437A01024 | 335.00% |
Cipla Ltd. INE059A01026 | 332.00% |
SAI LIFE SCIENCES LIMITED INE570L01029 | 308.00% |
Apollo Hospitals Enterprise Ltd. INE437A01024 | 308.00% |
SAI LIFE SCIENCES LIMITED INE570L01029 | 302.00% |
Lupin Ltd. INE326A01037 | 302.00% |
KRISHNA INSTITUTE OF MEDICAL INE967H01025 | 281.00% |
Aurobindo Pharma Ltd. INE406A01037 | 280.00% |
MANKIND PHARMA LTD INE634S01028 | 272.00% |
Ajanta Pharma Ltd. INE031B01049 | 266.00% |
Aurobindo Pharma Ltd. INE406A01037 | 264.00% |
JUBILANT PHARMOVA LIMITED INE700A01033 | 252.00% |
JUBILANT PHARMOVA LIMITED INE700A01033 | 249.00% |
ANTHEM BIOSCIENCES LTD INE0CZ201020 | 245.00% |
Glenmark Pharmaceuticals Ltd INE935A01035 | 243.00% |
Glenmark Pharmaceuticals Ltd INE935A01035 | 241.00% |
Alkem Laboratories Ltd. INE540L01014 | 240.00% |
Ajanta Pharma Ltd. INE031B01049 | 239.00% |
ANTHEM BIOSCIENCES LTD INE0CZ201020 | 237.00% |
Gland Pharma Limited INE068V01023 | 211.00% |
Alkem Laboratories Ltd. INE540L01014 | 207.00% |
RUBICON RESEARCH LIMITED INE506V01022 | 196.00% |
CORONA REMEDIES LIMITED INE02ZQ01018 | 193.00% |
CORONA REMEDIES LIMITED INE02ZQ01018 | 191.00% |
Marksans Pharma Ltd INE750C01026 | 186.00% |
EMCURE PHARMACEUTICALS LIMITED INE168P01015 | 180.00% |
Marksans Pharma Ltd INE750C01026 | 177.00% |
Gland Pharma Limited INE068V01023 | 176.00% |
RUBICON RESEARCH LIMITED INE506V01022 | 175.00% |
MANKIND PHARMA LTD INE634S01028 | 172.00% |
EMCURE PHARMACEUTICALS LIMITED INE168P01015 | 169.00% |
YATHARTH HOSPITAL AND TRAUMA CARE SERVICES LTD INE0JO301016 | 149.00% |
Dr.Reddy's Laboratories Ltd. INE089A01031 | 142.00% |
Performance Comparison
Interested in This Fund?
Our experts will help you decide if this fund fits your goals.
Compare with Similar Funds
Investment Objective
Kotak Healthcare Fund - Regular Plan - Growth Option invests in stocks from a specific sector or theme, offering concentrated exposure to a particular area of the economy. These funds carry sector-specific risks but can deliver significant returns when the underlying sector performs well.
About This Fund
Kotak Healthcare Fund - Regular Plan - Growth Option is a Sectoral / Thematic mutual fund offered by Kotak Mahindra Mutual Fund. The fund has been operational for over 2 years. It manages assets worth ₹462 Cr, reflecting investor confidence in the fund's strategy. It benchmarks its performance against Nifty Healthcare Index (Total Return Index). The current expense ratio is 2.34%.
Who Should Invest?
- •Investors with a high risk appetite seeking long-term wealth creation
- •Investors with an investment horizon of 5 years or more
- •SIP investors who can benefit from rupee cost averaging during market fluctuations